Pharmacokinetics and Comparative Bioavailability of Artesunate and Mefloquine Administered Separately or as a Fixed Combination Product to Healthy Volunteers and Patients with Uncomplicated Plasmodium falciparum Malaria.

Research Article - (2010) Volume 2, Issue 3

Piero Olliaro¹^*, Surash Ramanathan², Michel Vaillant³, Stephanie E Reuter⁴, Allan M Evans⁴, Srivicha Krudsood⁵, Sornchai Looareesuwan⁵, Jean-René Kiechel⁶, Walter RJ Taylor^1,⁷ and Visweswaran Navaratnam²: ¹UNICEF/UNDP/World Bank/WHO Special Programme for Research & Training in Tropical Diseases (TDR), Geneva, Switzerland; ²Centre for Drug Research, Universiti Sains Malaysia, Penang, Malaysia; ³Clinical Epidemiology and Public Health Unit, Centre for Health Studies, CRP-Santé, Luxembourg; ⁴School of Pharmacy & Medical Sciences, University of South Australia, Adelaide, Australia; ⁵Hospital for Tropical Disease, Bangkok, Thailand; ⁶Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland; ⁷Division of International and Humanitarian Medicine, Geneva, Swaziland

^*Corresponding Author: